loadpatents
Patent applications and USPTO patent grants for Lloyd-Evans; Emyr.The latest application filed is for "phosphorodiamidates and other phosphorus derivatives of fingolimod and related s1 p receptor modulators".
Patent | Date |
---|---|
Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulators Grant 11,078,221 - Lloyd-Evans , et al. August 3, 2 | 2021-08-03 |
Phosphorodiamidates And Other Phosphorus Derivatives Of Fingolimod And Related S1 P Receptor Modulators App 20200255460 - Kind Code | 2020-08-13 |
Treatment Of Mycobacterial Infection App 20180125796 - Platt; Frances Mary ;   et al. | 2018-05-10 |
Substrate reduction therapy Grant 9,428,541 - Platt , et al. August 30, 2 | 2016-08-30 |
Substrate Reduction Therapy App 20140080769 - Platt; Frances Mary ;   et al. | 2014-03-20 |
Substrate reduction therapy Grant 8,557,844 - Platt , et al. October 15, 2 | 2013-10-15 |
Substrate Reduction Therapy App 20100204162 - Platt; Mary Frances ;   et al. | 2010-08-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.